Our findings are similar to the findings by Sun et al. (1) in that this is a very select subgroup that has experienced an average of 41 years (range 31.2 49.4 years) of diabetes without any retinopathy.
As a consequence, these cohorts included a highly selected subgroup of lithium-treated patients since the outcome, i.e., hyperparathyroidism, was already present.
A randomly selected subgroup (n = 221) of women without the metabolic syndrome features, also underwent OGTT, and the results corroborated the very low prevalence of previously unknown diabetes among women outside the group.
A follow-up clinical examination in a randomly selected subgroup was performed in 2008 2009.
Apo A-V was analyzed in a randomly selected subgroup of the population; nevertheless, this subgroup was representative of the complete sample studied.
Independent associations between metabolic variables and apo A-V iAUC were also investigated in a randomly selected subgroup (n = 44).
Subsequently, in a randomly selected subgroup, we investigated factors associated with fasting and postprandial Apo A-V.
Samples of DNA were available from a randomly selected subgroup (812 subjects) of the cohort in the analysis.
Lung washes were performed on a randomly selected subgroup of mice from the above experimental series, and assayed for IgA.
NO consumption was subsequently measured in all plasma samples of a randomly selected subgroup of 13 patients.
